CAREFUSION: BD BURETTE GRAVITY SET 60 DROP 2 Smartsite VALVES VENTED/NONVENTED, REF: 42163E

Recall number

Z-2458-2021

Recalling firm

CAREFUSION

Product

BD BURETTE GRAVITY SET 60 DROP 2 Smartsite VALVES VENTED/NONVENTED, REF: 42163E

Status

Open, Classified

Initiated

2021-08-02

Posted

not on file

Terminated

not on file

Reason

Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.

Root cause

Process control

Action

On 08/02/21, Urgent Medical Device Correction notices were mailed and emailed to consignees who were asked to notify recalling firm if this issue was experienced at 1-844-823-5433, productcomplaints@bd.com . Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device. If during priming the clinician encounters an occluded needle-free connector, take the following actions: 1) Depress the syringe plunger while the syringe is still attached to the needle-free connector. 2) If unable to depress the plunger, pull back on the syringe plunger and depress the syringe plunger again. Repeating this step may assist in opening the needle-free connector valve. 3) If the valve still is not open; without disconnecting the syringe male luer tip from the BD SmartSite valve surface, carefully unthread and rethread the syringe to partially disengage and reengage the syringe. Repeating this step up to three times may assist in opening the needle-free valve. Note: To maintain sterility, do not allow the syringe and needle-free valve to completely disconnect. 4) If previous steps do not open the valve, then open a new needle-free connector to replace the occluded connector. 5) After the steps above, proceed with the existing instructions for use. 6) Share this correction notification with all users within your facility network of the product to ensure they are also aware of this correction. 7) Complete and return the Customer Response Form. Distributors were asked to identify customers within their distribution network that purchased the affected product and to email an excel file listing of all customers to the recalling firm within 72 hours of receipt of this letter so the recalling firm can initiate customer notification. See online tool to support the identification of impacted lot numbers https://www.bd.com/MDS-21-4144

Quantity

630

Distribution

Worldwide distribution - US Nationwide distribution in the states of FL, PA, NC, OH, SC, IL, RI, MO, NY, TN, AL, VA, PR, CA, NE, NJ, MI, MD, NM, LA, KY, NV, ME, OK, WA, MA, WV, TX, AR, OR, KS, GA, VT, IN, WY, AZ, CO, MN, WI, UT, SD, MS, ID, MT, ND, HI, IA, DC, AK, NH, CT, DE, GU and the countries of CA, NZ, TW, AU, BE, VN, AR, MY, TH, KR, ID, PH, SG, BH, SA, HK, IN, CN, BR.

Lot, serial or model codes

Lots: 21015553

510(k) numbers

["K820278"]

PMA numbers

not on file

Product code

FPA

Firm FEI

3012410077

Firm city

San Diego

Firm state

CA

Firm country

not on file

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Copy